Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

15 results
Display

Prophylaxis Against Hepatitis B Recurrence Following Liver Transplantation

Suh KS

  • KMID: 760575
  • Korean J Hepatol.
  • 2005 Mar;11(1):21-24.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic Factors of Postherpetic Neuralgia

Herr H

The investigation was aimed to determine prognostic factors related to postherpetic neuralgia (PHN), and treatment options for preventing PHN. The data showed 34 (17.0%) out of 188 patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Dose and Treatment Duration of Regimen

Kweon YO

  • KMID: 760573
  • Korean J Hepatol.
  • 2005 Mar;11(1):13-16.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of CMV Endotheliitis Treated with Intravitreal Ganciclovir Injection

Choi WS, Cho JH, Kim HK, Kim HS, Shin YJ

We report a case of CMV corneal endotheliitis that was treated with intravitreal ganciclovir injection. A 56-year-old man who has suffered from uveitis was referred to our clinic due to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antiviral effect of dietary germanium biotite supplementation in pigs experimentally infected with porcine reproductive and respiratory syndrome virus

Jung BG, Lee JA, Lee BJ

Germanium biotite (GB) is an aluminosilicate mineral containing 36 ppm germanium. The present study was conducted to better understand the effects of GB on immune responses in a mouse model,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pulmonary Toxicity by Pegylated Interferon alpha-2a in a Patient with Chronic Hepatitis C

Son BK, Sohn JH, Kim TY, Park YK, Jeon YC, Han DS

  • KMID: 760711
  • Korean J Hepatol.
  • 2007 Mar;13(1):103-107.
The combination therapy with pegylated interferon alpha and ribavirin has increasingly prescribed for chronic hepatitis C. Although many side effects of interferon such as flu-like symptoms, gastrointestinal and neuropsychiatric symptoms...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment Outcomes of Clevudine versus Lamivudine at Week 48 in Naive Patients with HBeAg Positive Chronic Hepatitis B

Kim IH, Lee S, Kim SH, Kim SW, Lee SO, Lee ST, Kim DG, Choi CS, Kim HC

The authors assessed the efficacy and antiviral resistance of 48-week clevudine therapy versus lamivudine in treatment of naive patients with HBeAg positive chronic hepatitis B. In this retrospective study, a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-Term Outcomes and Dynamics of Mutants Associated with Lamivudine-Adefovir Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B

Kim J, Lee SH, Kim HS, Choi K, Jeong SW, Kim SG, Jang JY, Kim YS, Kim BS

BACKGROUND/AIMS: To investigate the association between the baseline profiles and dynamics of hepatitis B virus (HBV) DNA polymerase gene mutations and the long-term virological response of lamivudine (LAM)-adefovir (ADV) combination...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of severe hypophosphatemia related to adefovir dipivoxil treatment in a patient with liver cirrhosis related to hepatitis B virus

Lee HJ, Choi JW, Kim TN, Eun JR

Adefovir dipivoxyl (ADV) effectively suppresses hepatitis B virus (HBV) replication but exhibits nephrotoxicity with severe hypophosphatemia when administered at a high dosage. This is the first report of severe hypophosphatemic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Severe influenza treatment guideline

Choi WS, Baek JH, Seo YB, Kee SY, Jeong HW, Lee HY, Eun BW, Choo EJ, Lee J, Kim YK, Song JY, Wie SH, Lee JS, Cheong HJ, Kim WJ, Transgovernmental Enterprise for Pandemic Influenza in Korea

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis

Lee J, Park JH, Jwa H, Kim YH

PURPOSE: Peramivir is the first intravenously administered neuramidase inhibitor for immediate delivery of an effective single-dose treatment in patients with influenza. However, limited data are available on intravenous (IV) peramivir...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C

Kim KT, Han SY, Kim JH, Yoon HA, Baek YH, Kim MJ, Lee SW, Jang JS, Lee JH, Roh MH

BACKGROUND/AIMS: The purpose of this study is to elucidate the efficacy and safety of combined peginterferon and ribavirin therapy in Korean patients with chronic HCV infection. METHODS: We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Efficacy and Safety of Telbivudine in Korean Patients with Chronic Hepatitis B

Moon YM, Hwang SG, Kim BS, Rim KS, Cho M, Kim DJ, Han JY, Kim YS, Choi HS, Ahn SH

BACKGROUND AND AIMS: Telbivudine is an L-nucleoside analogue with potent antiviral activity against hepatitis B virus (HBV). Clinical trials have shown that telbivudine is more potent than lamivudine for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Change of HBV DNA Level as a Predictor of HBeAg Loss after Lamivudine Treatment

Jung JK, Lee CH, Kim EY, Jung JT, Choi JH, Han JM, Jin MI, Cho JY, Kim BS, Shin IH

BACKGROUND AND AIMS: Lamivudine is an effective, safe therapeutic agent for the treatment of chronic hepatitis B. The aim of this study was to investigate whether early suppression of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recurrence and Management of Hepatitis C after Liver Transplantation

Oh KB, Lee SG, Lee YJ, Park KM, Hwang S, Kim KH, Ahn CS, Moon DB, Chu CW, Yang HS, Ha TY, Cho SH

  • KMID: 863153
  • Korean J Hepatol.
  • 2003 Sep;9(3):180-187.
BACKGROUND/AIMS: End-stage liver disease caused by viral hepatitis C has been increasing recently in Korea. In this study, we investigated the clinical progress, recurrence, and management of hepatitis C patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr